STRIDES PHARMA SCIENCE LIMITED

Scale -

Ebitda is 1076 Rs Cr; Annual Growth is 25 %; Continuous Growth over 3 years; 5 Year CAGR is 76 %
PBT is 201 Rs Cr; Annual Growth is 38 %
Revenue is 4859 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 12 %

PAT is 574 Rs Cr; Annual Decline is -84 %

Profitability -

PBDIT Margin is 22.14 %; Annual Growth is 17 %; 5 Year CAGR is 57 %; in Bottom Quartile

PAT Margin is 11.81 %; Annual Decline is -85 %
Quarterly Ebitda Margin is 18 %; in Bottom Quartile

Return -

ROCE is 21.66 %; Continuous Growth over 3 years
Asset Turnover is 75 %; 5 Year CAGR is 24 %

ROA is 8.02 %; Annual Decline is -86 %
ROE is 17.89 %; Annual Decline is -87 %

Efficiency -

Current Ratio is 1.25; Continuous Growth over 3 years; in Bottom Quartile
Inventory Turnover Ratio is 3.34; 5 Year CAGR is 32 %; in Bottom Quartile

Quick Ratio is 0.68; in Bottom Quartile

Solvancy -

Debt/Equity is 0.54; Continuous Decline over 3 years; in Top Quartile
Long term Debt is 552 Rs Cr; Continuous Decline over 3 years
Total Debt is 1669 Rs Cr; Continuous Decline over 3 years
Contingent Liabilities is 280 Rs Cr; 5 Year CAGR is -31 %; Annual Growth is 42 %

Quality -

Operating cashflow/PAT is 122 %; Annual Growth is 543 %
Exceptional Items/PBT is -4 %; Annual Decline is -130 %
Current Tax/PAT is 14 %; in Bottom Quartile; 5 Year CAGR is -24 %; Annual Growth is 940 %
Change in Inventories/Total Expenses is 1 %; 5 Year CAGR is -24 %; Annual Growth is 120 %; in Top Quartile

Operating cashflow/ebitda is 65 %; Continuous Decline over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: